Literature DB >> 31633879

Mometasone absorption in cultured airway epithelium.

Tuong T Nguyen1, Paul S Soma2, Teresa Mascenik1, Catherine A Lewis1, Rhianna E Lee1,3, Brian D Thorp4, Adam M Zanation4,5, Charles S Ebert4, Brent A Senior4, Scott H Randell1,3, Brandie M Ehrmann2, Adam J Kimple1,4,5.   

Abstract

BACKGROUND: Topical mometasone is frequently used as an intranasal spray, on drug-eluting stents, and compounded by specialty pharmacies as a sinus rinse. A typical sinus rinse contains 1.2 mg of mometasone dissolved in 240 mL of buffered saline and is flushed through the sinonasal cavity. The mometasone irrigation rapidly flows to the contralateral sinonasal cavity or the nasopharynx with a contact time on the order of 5 to 10 seconds. However, no information is available on the absorption rate of topical mometasone on the sinonasal surface.
METHODS: To determine the absorption characteristics of mometasone, we harvested nasal epithelium from 2 healthy donors and differentiated them into a mature ciliated epithelium on Millicell membranes. We applied mometasone to the apical surface for various time intervals and then rinsed off non-absorbed mometasone with phosphate-buffered saline. Millicell membranes with the adherent epithelial cells were then harvested and stored in guanidine hydrochloride for quantification using high-performance liquid chromatography-mass spectrometry.
RESULTS: Fifty percent of the maximal absorption occurred after an average of 38 minutes after application, and maximal absorption occurred after an average of 114 minutes.
CONCLUSION: Our data provide an estimate for rates of absorption of mometasone applied to the sinonasal cavity and suggest that the absorption rates poorly match contact time during saline lavage.
© 2019 ARS-AAOA, LLC.

Entities:  

Keywords:  allergic rhinitis; intranasal corticosteroids; nasal irrigations; steroid rinses

Mesh:

Substances:

Year:  2019        PMID: 31633879      PMCID: PMC6927533          DOI: 10.1002/alr.22441

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  21 in total

1.  Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study.

Authors:  Lauren J Luk; Toby O Steele; Jess C Mace; Zachary M Soler; Luke Rudmik; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2015-07-03       Impact factor: 3.858

2.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

3.  Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens.

Authors:  Xuefeng Liu; Ewa Krawczyk; Frank A Suprynowicz; Nancy Palechor-Ceron; Hang Yuan; Aleksandra Dakic; Vera Simic; Yun-Ling Zheng; Praathibha Sripadhan; Chen Chen; Jie Lu; Tung-Wei Hou; Sujata Choudhury; Bhaskar Kallakury; Dean G Tang; Thomas Darling; Rajesh Thangapazham; Olga Timofeeva; Anatoly Dritschilo; Scott H Randell; Christopher Albanese; Seema Agarwal; Richard Schlegel
Journal:  Nat Protoc       Date:  2017-01-26       Impact factor: 13.491

Review 4.  A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.

Authors:  C Crim; L N Pierre; P T Daley-Yates
Journal:  Clin Ther       Date:  2001-09       Impact factor: 3.393

5.  Human nasal and tracheo-bronchial respiratory epithelial cell culture.

Authors:  M Leslie Fulcher; Scott H Randell
Journal:  Methods Mol Biol       Date:  2013

Review 6.  Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy.

Authors:  Günther Hochhaus
Journal:  Clin Ther       Date:  2008-01       Impact factor: 3.393

Review 7.  Chronic rhinosinusitis: the rationale for current treatments.

Authors:  Nsangou Ghogomu; Robert Kern
Journal:  Expert Rev Clin Immunol       Date:  2016-08-24       Impact factor: 4.473

Review 8.  Risks and management of long-term corticosteroid use in chronic rhinosinusitis.

Authors:  Raewyn G Campbell
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2018-02       Impact factor: 2.064

9.  Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis.

Authors:  Kornkiat Snidvongs; Eleanor Pratt; David Chin; Raymond Sacks; Peter Earls; Richard J Harvey
Journal:  Int Forum Allergy Rhinol       Date:  2012-05-07       Impact factor: 3.858

10.  ImageJ2: ImageJ for the next generation of scientific image data.

Authors:  Curtis T Rueden; Johannes Schindelin; Mark C Hiner; Barry E DeZonia; Alison E Walter; Ellen T Arena; Kevin W Eliceiri
Journal:  BMC Bioinformatics       Date:  2017-11-29       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.